Profil
David M.
Floyd served as Executive Vice President and Chief Scientific Officer of Pharmacopeia, Inc. from February 2005 to March 31, 2008.
He was Vice President of Discovery Chemistry for Bristol-Myers Squibb Company from 1992 to June 2003 and Co-Chairman of the Drug Discovery Committee.
Dr. Floyd received a PhD in Organic Chemistry from the University of Michigan and a BA degree in Biological Science from San Francisco State University.
Anciens postes connus de David M. Floyd
| Sociétés | Poste | Fin |
|---|---|---|
Pharmacopeia LLC
 Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Directeur Technique/Scientifique/R&D | 31/03/2008 |
Formation de David M. Floyd
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
